iScience (Aug 2024)

Multiplex spatial omics reveals changes in immune-epithelial crosstalk during inflammation and dysplasia development in chronic IBD patients

  • Matthijs J.D. Baars,
  • Evelien Floor,
  • Neeraj Sinha,
  • José J.M. ter Linde,
  • Stephanie van Dam,
  • Mojtaba Amini,
  • Isaäc J. Nijman,
  • Joren R. ten Hove,
  • Julia Drylewicz,
  • G.Johan A. Offerhaus,
  • Miangela M. Laclé,
  • Bas Oldenburg,
  • Yvonne Vercoulen

Journal volume & issue
Vol. 27, no. 8
p. 110550

Abstract

Read online

Summary: Patients with long-standing inflammatory bowel disease (IBD) face an increased risk of developing colitis-associated cancer (CAC). Although IBD-induced prolonged inflammation seems to be involved in CAC pathogenesis, the specific molecular changes that contribute remain unknown. Here, we applied digital spatial RNA profiling, RNAscope, and imaging mass cytometry to examine paired uninflamed, inflamed, and early dysplastic mucosa of patients with IBD. We observed robust type 3 (IL-17) responses during inflammation, accompanied by elevated JAK-STAT signaling and phosphorylated STAT3 (P-STAT3) levels, with both inflamed and dysplastic mucosa displaying immune cell activation. Higher stromal P-STAT3 was detected in uninflamed and inflamed mucosa of patients who eventually developed dysplasia. CD8a+ T cells did not infiltrate inflamed or dysplastic epithelial regions in these patients, while control patients showed elevated CD8a in inflamed mucosa. Our study reveals distinct inflammatory patterns throughout CAC development, marked by an activated IL-17 pathway, engaged STAT3, and diminished cytotoxic T cell infiltration.

Keywords